Sight Sciences, Inc.
SGHT
$3.63
$0.164.61%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.87% | -1.25% | -8.45% | -9.12% | 1.72% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.87% | -1.25% | -8.45% | -9.12% | 1.72% |
| Cost of Revenue | 3.34% | -16.65% | -1.59% | -13.57% | -9.47% |
| Gross Profit | 7.41% | 1.72% | -9.58% | -8.37% | 3.67% |
| SG&A Expenses | -21.40% | -14.71% | -10.54% | -7.67% | 2.28% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.41% | -20.31% | -8.20% | -7.71% | 3.82% |
| Operating Income | 69.24% | 54.54% | 7.78% | 5.87% | -7.37% |
| Income Before Tax | 64.82% | 24.33% | 3.35% | 13.15% | -10.55% |
| Income Tax Expenses | -78.95% | -147.59% | 166.67% | 141.18% | 280.00% |
| Earnings from Continuing Operations | 64.87% | 26.18% | 3.15% | 12.98% | -10.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 64.87% | 26.18% | 3.15% | 12.98% | -10.80% |
| EBIT | 69.24% | 54.54% | 7.78% | 5.87% | -7.37% |
| EBITDA | 69.70% | 54.84% | 7.40% | 5.65% | -7.32% |
| EPS Basic | 66.38% | 29.03% | 6.76% | 16.03% | -6.68% |
| Normalized Basic EPS | 66.35% | 51.96% | 6.94% | 4.66% | -6.45% |
| EPS Diluted | 66.38% | 29.03% | 6.76% | 16.03% | -6.68% |
| Normalized Diluted EPS | 66.35% | 51.96% | 6.94% | 4.66% | -6.45% |
| Average Basic Shares Outstanding | 4.52% | 4.05% | 3.84% | 3.65% | 3.89% |
| Average Diluted Shares Outstanding | 4.52% | 4.05% | 3.84% | 3.65% | 3.89% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |